Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Lodivixx vs Exforge in Healthy Males
NCT03648333Phase 1Completed
- Sponsor
- Hanlim Pharm
- Start
- Dec 2013
- Primary completion
- Feb 2014
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of s-amlodipine + valsartan in hypertension (HTN) (2 arms), sponsored by Hanlim Pharm. Primary endpoints: Maximum Concentration and Area Under Curve. Started Dec 2013; status: completed.
02
Drugs
s-amlodipine + valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03648333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03648333.